Skip to main content

Table 1 (abstract O6). Change in HbA1c in mmol/mol at 6 months (with 95% confidence intervals) per standard deviation greater baseline value of predictor. A negative value represents a reduction (improvement) in HbA1c

From: Methods for Evaluation of medical prediction Models, Tests And Biomarkers (MEMTAB) 2018 Symposium

  a) SGLT-inhibitors b) DPP4-inhibitors
  Baseline HbA1c eGFR HDL Baseline HbA1c BMI Triglycerides
CPRD -9.5 (-9.8;-9.0) -1.75 (-2.2;-1.3) 2.2 (1.5;2.9) -8.4 (-8.6;-8.2) 1.0 (0.8;1.1) 0.9 (0.6;1.1)
Trials -5.8 (-6.1;-5.5) -1 (-1.3;0.7) 0.6 (0.3;0.8) -4.7 (-5.5;-3.9) 0.4 (0.0;0.9) 0.5 (0.1;1.0)